MDA-9 inhibitors for aggressive liver cancer?
Researchers have published new study findings that establish rationale for the use of a class of drugs known as MDA-9 inhibitors as a potential treatment option for aggressive liver cancer.
Materials provided by Virginia Commonwealth University. Original written by Blake Belden. Note: Content may be edited for style and length.
Source link aaaaa